Aeon BioHealth is a duly organized Navada company settled in Lakeland Florida, engaged in the development and formulation of epidermal transdermal patches using Pharmaceutical and Naturaceuticals. Our products us its proprietary drug delivery technologies and know-how in order to offer both innovative formulations of well-established drugs and generic versions of marketed products.
Aeon BioHealth Inc. is a science-based biotechnology company that integrates nutraceuticals, pharmaceuticals, and informatics to advance precision medicine intervention to prevent and treat Autoimmune and Chronic Depression.
AB is a preclinical-stage biotech company developing novel first-in-class therapeutics for pain, inflammation, and depression. Current medications have limited efficacy and significant side effects.
There is an unmet clinical need for more effective and safer therapeutics. AB’s products are transdermal based, safer, and more effective than current therapies, plus they target a novel modem of apparatus.
Brings together global leaders in their fields who are dedicated to serving the AEON BIO-HEALTH mission and purpose.
Jermaine T. Johnson
Kyle Dijon Hill, MD MSCR
Chief Medical Officer
DR. David A Dawson
Chief Science Officer
Founder and CEO
The statements made regarding these products have not been evaluated by the Food and Drug Administration. The efficacy of these products has not been confirmed by FDA-approved research. These products are not intended to diagnose, treat, cure or prevent any disease. All information presented here is not meant as a substitute for or alternative to information from health care practitioners. Please consult your health care professional about potential interactions or other possible complications before using any product. The Federal Food, Drug and Cosmetic Act requires this notice.